A Catalyst for Collaboration
Targeting Chromophobe Kidney Cancer Tumors
Meet the Expert
Cystic Lung Disease in BHD
Cystic Lung Disease in BHD
Highlights from the 2022 International LAM Research Conference
Using Research Discoveries in Treatment
LAM: From Puzzle to Treatment
The Air We Breathe
Interview with Professor Elizabeth Henske
Spotlight on Chromophobe RCC
Interview with Lisa Henske
Interview with Lisa Henske
Today’s Voice of Kidney Cancer is Dr. Elizabeth (Lisa) Henske, who runs the Henske Lab at Brigham and Women’s Hospital and Harvard Medical School in Boston. One of her principal areas of research is chromophobe renal cell carcinoma (chRCC). She’s also one of the newest members of the KCCure scientific advisory board. We’re grateful to Dr. Henske for donating her time to answer a few questions about her work in chRCC.